A high-resolution integrated analysis of genetic and expression profiles of breast cancer cell lines

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Breast Cancer Research and Treatment

• Publication date

  2009-01-24

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10549-008-0296-7PMID 19169812
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Culture of Animal Cells: A Manual of Basic Technique and Specialized Applications

  2010cited by this paper
• Predicting protein-protein interactions in Arabidopsis thaliana through integration of orthology, gene ontology and co-expression

  2009influential reference
• Metaplastic breast carcinomas are basal-like breast cancers: a genomic profiling analysis

  2009cited by this paper
• Tiling Path Genomic Profiling of Grade 3 Invasive Ductal Breast Cancers

  2009cited by this paper
• ESR1 gene amplification in breast cancer: a common phenomenon?

  2008cited by this paper
• Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancer.

  2008cited by this paper
• ESR1 gene amplification in breast cancer: a common phenomenon?

  2008cited by this paper
• ESR1 gene amplification in breast cancer: a common phenomenon?

  2008cited by this paper
• ESR1 gene amplification in breast cancer: a common phenomenon?

  2008cited by this paper
• Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines

  2008cited by this paper
• The genomic profile of HER2‐amplified breast cancers: the influence of ER status

  2008influential reference
• Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing

  2008cited by this paper
• Drug delivery with carbon nanotubes for in vivo cancer treatment.

  2008cited by this paper
• Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast

  2008influential reference
• Basal-like breast cancer: a critical review.

  2008cited by this paper
• Distribution and significance of caveolin 2 expression in normal breast and invasive breast cancer: an immunofluorescence and immunohistochemical analysis

  2008cited by this paper
• Analysis by array CGH of genomic changes associated with the progression or relapse of Wilms' tumour

  2007influential reference
• High‐resolution genomic profiles of breast cancer cell lines assessed by tiling BAC array comparative genomic hybridization

  2007cited by this paper
• Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer

  2007cited by this paper
• High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer

  2007influential reference
• Caveolin 1 Is Overexpressed and Amplified in a Subset of Basal-like and Metaplastic Breast Carcinomas: A Morphologic, Ultrastructural, Immunohistochemical, and In situ Hybridization Analysis

  2007cited by this paper
• Evaluation of Phi29-based whole-genome amplification for microarray-based comparative genomic hybridisation

  2007cited by this paper
• Molecular response to aromatase inhibitor treatment in primary breast cancer

  2007cited by this paper
• Utilizing RNA interference to enhance cancer drug discovery

  2007cited by this paper
• Integrated profiling of basal and luminal breast cancers.

  2007influential reference
• Genomic and transcriptional aberrations linked to breast cancer pathophysiologies.

  2006cited by this paper
• Novel patterns of genome rearrangement and their association with survival in breast cancer.

  2006influential reference
• Advances in Brief Comparative Genomic in Situ Hybridization of Colon Carcinomas with Replication Error '

  2006cited by this paper
• A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes.

  2006cited by this paper
• Genomic analysis of tumors by array comparative genomic hybridization: more is better.

  2006cited by this paper
• FGFR1 Emerges as a Potential Therapeutic Target for Lobular Breast Carcinomas

  2006cited by this paper
• Microarray-based comparative genomic hybridisation of breast cancer patients receiving neoadjuvant chemotherapy

  2006influential reference
• EGFR amplification and lack of activating mutations in metaplastic breast carcinomas

  2006cited by this paper
• Gene expression profiling of breast cell lines identifies potential new basal markers

  2006cited by this paper
• Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene‐expression subtypes of breast cancer

  2006cited by this paper
• Overexpression of RB1 transcript is significantly correlated with 13q14 allelic imbalance in colorectal carcinomas

  2006cited by this paper
• Prognosis and Gene Expression Profiling of 20q13-Amplified Breast Cancers

  2006cited by this paper
• Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entity

  2005cited by this paper
• Identification of molecular apocrine breast tumours by microarray analysis

  2005cited by this paper
• Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy

  2005cited by this paper
• Culture of animal cells : a manual of basic technique

  2005cited by this paper
• Molecular classification and molecular forecasting of breast cancer: ready for clinical application?

  2005cited by this paper
• Comprehensive Profiling of 8p11-12 Amplification in Breast Cancer

  2005cited by this paper
• Expression profiling of purified normal human luminal and myoepithelial breast cells: identification of novel prognostic markers for breast cancer.

  2004cited by this paper
• Genomic and Expression Profiling of Chromosome 17 in Breast Cancer Reveals Complex Patterns of Alterations and Novel Candidate Genes

  2004cited by this paper
• The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers

  2004cited by this paper
• Relevance of Breast Cancer Cell Lines as Models for Breast Tumours: An Update

  2004cited by this paper
• Identification of an epigenetically silenced gene, RFX1, in human glioma cells using restriction landmark genomic scanning

  2004cited by this paper
• Identification of microsatellite instability and mismatch repair gene mutations in breast cancer cell lines

  2003cited by this paper
• Repeated observation of breast tumor subtypes in independent gene expression data sets

  2003cited by this paper
• Mutational status of overexpressed p16 in head and neck cancer: evidence for germline mutation of p16/p14ARF.

  2002cited by this paper
• Diagnosis of multiple cancer types by shrunken centroids of gene expression

  2002cited by this paper
• Conditional immortalization of freshly isolated human mammary fibroblasts and endothelial cells.

  2001cited by this paper
• Molecular portraits of human breast tumours

  2000cited by this paper
• Mutations in the NSDHL gene, encoding a 3beta-hydroxysteroid dehydrogenase, cause CHILD syndrome.

  2000cited by this paper
• Comparative genomic in situ hybridization of colon carcinomas with replication error.

  1995cited by this paper
• Controlling the false discovery rate: a practical and powerful approach to multiple testing

  1995cited by this paper
• An immunomagnetic separation method using superparamagnetic (MACS) beads for large-scale purification of human mammary luminal and myoepithelial cells.

  1994cited by this paper
• Analysis of proviral integration in human mammary epithelial cell lines immortalized by retroviral infection with a temperature‐sensitive SV40 T‐antigen construct

  1994cited by this paper
• Expression of p53 gene in 184 unifocal hepatocellular carcinomas: association with tumor growth and invasiveness.

  1993cited by this paper
• Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies.

  1991cited by this paper
• More is better.

  1988cited by this paper

• Structural and mechanistic insights into peptidylarginine deiminase (PAD2/PAD4) mediated citrullination and therapeutic targeting: A review.

  2025cites this paper
• Peptidylarginine deiminase enzymes and citrullinated proteins in female reproductive physiology and associated diseases

  2022cites this paper
• Breast cancer-secreted factors induce atrophy and reduce basal and insulin-stimulated glucose uptake by inhibiting Rac1 activation in rat myotubes

  2020cites this paper
• Bioinformatics analysis of the genes involved in the extension of proCriteriastate cancer to adjacent lymph nodes by supervised and unsupervised machine learning methods: The role of SPAG1 and PLEKHF2.

  2020cites this paper
• Peptidyl Arginine Deiminase 2 (PADI2)-Mediated Arginine Citrullination Modulates Transcription in Cancer

  2020cites this paper
• The Detection and Morphological Analysis of Circulating Tumor and Host Cells in Breast Cancer Xenograft Models

  2019cites this paper
• An Effect of Culture Media on Epithelial Differentiation Markers in Breast Cancer Cell Lines MCF7, MDA-MB-436 and SkBr3

  2018cites this paper
• The Wnt Signaling Landscape of Mammary Stem Cells and Breast Tumors.

  2018cites this paper
• Tissue Expression of Prohibition-I and It’s Relationship With Prognostic Factors in Breast Cancer

  2018cites this paper
• Identification of PADI 2 as a potential breast cancer biomarker and therapeutic target

  2017cites this paper
• TARGETING AUTOPHAGY TO IMPROVE EFFICACY OF CDK4/6 INHIBITION IN BREAST CANCER

  2017cites this paper
• Profiling of microRNAs in tumor interstitial fluid of breast tumors – a novel resource to identify biomarkers for prognostic classification and detection of cancer

  2016cites this paper
• Squalene epoxidase is a bona fide oncogene by amplification with clinical relevance in breast cancer

  2016cites this paper
• Multi-Scale Genomic, Transcriptomic and Proteomic Analysis of Colorectal Cancer Cell Lines to Identify Novel Biomarkers

  2015cites this paper
• Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast

  2014cites this paper
• Protein Deimination in Human Health and Disease

  2014cites this paper
• Increased macroH2A1.1 Expression Correlates with Poor Survival of Triple-Negative Breast Cancer Patients

  2014cites this paper
• Integrative molecular and functional profiling of ERBB2-amplified breast cancers identifies new genetic dependencies

  2014cites this paper
• TPD52 represents a survival factor in ERBB2‐amplified breast cancer cells

  2014cites this paper
• CUL4A contributes to the biology of basal-like breast tumors through modulation of cell growth and antitumor immune response

  2014cites this paper
• Isolation of breast cancer and gastric cancer circulating tumor cells by use of an anti HER2-based microfluidic device.

  2014cites this paper
• Steroid receptor crosstalk in breast cancer cells.

  2014cites this paper
• Towards functional multiscale analysis of colorectal cancer

  2014cites this paper
• Integrative genomic and transcriptomic characterization of papillary carcinomas of the breast

  2014cites this paper
• Picking the PAD Lock: Chemical and Biological Approaches to Identify PAD Substrates and Inhibitors

  2014cites this paper
• Identification Of Peptidylarginine Deiminase-2 (Padi2) As A Potential Oncogene And Therapeutic Target

  2014cites this paper
• Retinoic acid receptor alpha amplifications and retinoic acid sensitivity in breast cancers.

  2013cites this paper
• Inhibiting Tumor Protein D52 function for anti-cancer therapy application

  2013cites this paper
• Perturbation of the heparin/heparin-sulfate interactome of human breast cancer cells modulates pro-tumourigenic effects associated with PI3K/Akt and MAPK/ERK signalling

  2013cites this paper
• An siRNA screen identifies the GNAS locus as a driver in 20q amplified breast cancer

  2013cites this paper
• Proteomic analysis of two metabolic proteins with potential to translocate to plasma membrane associated with tumor metastasis development and drug targets.

  2013cites this paper
• ROCK: a resource for integrative breast cancer data analysis

  2013cites this paper
• Identification of PADI2 as a potential breast cancer biomarker and therapeutic target

  2012cites this paper
• Functional characterization of the 19q12 amplicon in grade III breast cancers

  2012influential citation
• [Utility of chromosome banding with ALU I enzyme for identifying methylated areas in breast cancer].

  2012cites this paper
• ESR 1 Is Co-Expressed with Closely Adjacent Uncharacterised Genes Spanning a Breast Cancer Susceptibility Locus at 6 q 25 . 1

  2012cites this paper
• Immunophenotypic and genomic characterization of papillary carcinomas of the breast

  2012cites this paper
• Genomic profiling of mitochondrion-rich breast carcinoma: chromosomal changes may be relevant for mitochondria accumulation and tumour biology

  2012cites this paper
• Molecular characterisation of cell line models for triple-negative breast cancers

  2012cites this paper
• NT5E CpG island methylation is a favourable breast cancer biomarker

  2012cites this paper
• Potential oncogenes within the 8p12-p11 amplicon. Identification and functional testing in breast cancer cell lines

  2012influential citation
• Utilidad del bandeo cromosómico con la enzima ALU I para la identificación de zonas metiladas en cáncer de mama

  2012cites this paper
• CHARACTERIZATION OF ZHX1 IN AXILLARY LYMPH NODE-NEGATIVE BREAST CANCER

  2012influential citation
• Hugsanleg æxlisgen á 8p12-p11 mögnunarsvæðinu Æxlisgen tilgreind og prófuð í brjóstakrabbameinsfrumulínum

  2012cites this paper
• CHARACTERIZATION OF ZHX 1 IN AXILLARY LYMPH NODE-NEGATIVE BREAST CANCER

  2012influential citation
• Update on the molecular profile of the MDA-MB-453 cell line as a model for apocrine breast carcinoma studies.

  2011cites this paper
• ESR1 Is Co-Expressed with Closely Adjacent Uncharacterised Genes Spanning a Breast Cancer Susceptibility Locus at 6q25.1

  2011cites this paper
• Deficiency in trefoil factor 1 (TFF1) increases tumorigenicity of human breast cancer cells and mammary tumor development in TFF1-knockout mice

  2011cites this paper
• Low-grade and high-grade invasive ductal carcinomas of the breast follow divergent routes of progression

  2011cites this paper
• The Molecular Evolution of Breast Cancer Precursors and Risk Indicators

  2011cites this paper
• Comprehensive Genomic Analysis of a BRCA2 Deficient Human Pancreatic Cancer

  2011cites this paper
• Choosing the right cell line for breast cancer research

  2011cites this paper
• Bioengineering Embryonic Stem Cell Microenvironments for the Study of Breast Cancer

  2011cites this paper
• The DNA Replication Initiation Machinery as a Target for Cancer Diagnosis and Therapy

  2011cites this paper
• FACULTE DE MEDECINE DE TOURS

  2011cites this paper
• Influence of whole arm loss of chromosome 16q on gene expression patterns in oestrogen receptor‐positive, invasive breast cancer

  2011cites this paper
• Gene expression following ionising radiation: Identification of biomarkers for dose estimation and prediction of individual response

  2011cites this paper
• Functional characterization of EMSY gene amplification in human cancers

  2011cites this paper
• ROCK: a breast cancer functional genomics resource

  2010cites this paper
• Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer

  2010cites this paper
• Mucinous carcinoma of the breast is genomically distinct from invasive ductal carcinomas of no special type

  2010cites this paper
• Subtypes of familial breast tumours revealed by expression and copy number profiling

  2010cites this paper
• STRATEGIES FOR THE IDENTIFICATION OF ALLELES INVOLVED IN HEREDITARY BREAST CANCER

  2010cites this paper
• ZNF217 confers resistance to the pro-apoptotic signals of paclitaxel and aberrant expression of Aurora-A in breast cancer cells

  2010cites this paper
• An integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancers

  2010cites this paper
• Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomas

  2010cites this paper
• Breast cancer precursors revisited: molecular features and progression pathways

  2010cites this paper
• Targeting DNA replication before it starts: Cdc7 as a therapeutic target in p53-mutant breast cancers.

  2010cites this paper
• Cortactin gene amplification and expression in breast cancer: a chromogenic in situ hybridisation and immunohistochemical study

  2010cites this paper
• Tumor and Stem Cell Biology Cancer Research FGFR 1 Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer

  2010cites this paper
• FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer.

  2010cites this paper
• DNA amplifications in breast cancer: genotypic-phenotypic correlations.

  2010cites this paper
• Breast cancer cell lines carry cell line-specific genomic alterations that are distinct from aberrations in breast cancer tissues: Comparison of the CGH profiles between cancer cell lines and primary cancer tissues

  2010cites this paper
• MOLECULAR ANALYSIS OF SPECIAL TYPES BREAST CARCINOMAS

  2010cites this paper
• Composite cervical adenocarcinoma composed of adenoma malignum and gastric type adenocarcinoma (dedifferentiated adenoma malignum) in a patient with Peutz Jeghers syndrome

  2010cites this paper
• Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets

  2009influential citation
• Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas

  2009cites this paper